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 INTRODUCTION 
    
  “Spinal Anaesthesia”  plays an important role in alleviating pain intraoperatively.
 The term “Spinal Anaesthesia” was coined by J. Leonard Corning in 1885. 
 In 1898, the first deliberate spinal anaesthesia was given to August Karl Gustav 
Bier by his assistant Dr.Hildebrandt.  The second attempt was done on the theca of 
Dr.Hildebrandt.  Twenty three minutes after the injection of cocaine, Dr. Bier noted “A 
strong blow with an iron hammer against the tibia was not felt as pain.” 
 First planned spinal analgesia was performed by Bier on 16th August 1898, in 
Kiel, when he  injected 3 ml of 0.5% cocaine solution  to a 34 year old labourer.  
 This was followed  by successful  and enthusiastic practice of spinal anaesthesia 
by “Rudolp Matas’ in New  Orleans and “Theodore Tuffier”in France. 
 For lower extremity and perineal surgeries the standard and most frequently 
employed technique is subarachnoid block. It provides superior analgesia and reduces 
perioperative complications (eg. Nausea, vomiting, dizziness, lethargy) compared with 
general anesthesia. 
 Injection Lignocaine, Bupivacaine (isobaric and hyperbaric)                   
Ropivacaine (isobaric and hyperbaric) are the common drugs used for spinal anaesthesia. 
 Lignocaine has faster onset and short duration of sensory and motor block which 
is ideal for short procedures (1 – 1 ½ hrs).  The disadvantage of it, is the hypotension and 
bradycardia which occurs soon after subarachnoid block and transient neurological 
symptoms. 
 Short acting  local anaesthetics such as plain 2-chloroprocaine  have been used 
with success for surgical procedures lasting an hour or less, with no reports of transient 
neurological symptoms. 
 Bupivacaine is the commonly used drug, which is of intermediate to long 
duration. But in the ambulatory anaesthesia, usage of Bupivacaine is disadvantageous  
because of residual motor and sympathetic blockade which can delay discharge, delayed 
ambulation and urinary retention. 
 So for a long time a suitable alternative to Bupivacaine was on research and 
Ropivacaine was introduced.  It is available as isobaric solution and can be made 
hyperbaric by adding dextrose.   
 The duration of onset of sensory block, onset of motor block and highest sensory 
level reached, are longer but the offset of sensory and motor block, two segment 
regression time and the time of urination are shorter  for Ropivacaine.  The lower lipid 
solubility of Ropivacaine is the cause for delayed onset of sensory block. Ropivacaine 
has a good hemodynamic stability. Cardiovascular and central nervous system toxicity 
are less in Ropivacaine when  compared to Bupivacaine. 
Hence this study, is to evaluate the effect of equal doses of intrathecal isobaric 
Bupivacaine and isobaric Ropivacaine in terms of duration of analgesia and changes in 
hemodynamic variables.  
  
  
 
 
 
  
 
 
 
 
 
AIM OF STUDY 
 
 The aim of this study is to evaluate the effect of equal doses of intrathecal 
isobaric Bupivacaine and isobaric Ropivacaine in terms of duration of analgesia 
and haemodynamic parameters. 
 
 
 
 
 
 
 
 
 
 
 
  
ANATOMY OF SPINAL CORD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANATOMY OF SUBARACHNOID SPACE 
 
 Subarachnoid block means the temporary interruption of nerve transmission 
within the subarachnoid space produced by injection of a local anaesthetic solution into 
cerebrospinal fluid. 
 
Applied anatomy of vertebral canal: 
 Vertebral canal extends from foramen magnum to the sacral hiatus.  
It protects the spinal cord. 
 The vertebral column comprises 33 vertebrae (7-cervical, 12-thoracic, 5-lumbar, 
5-fused sacral and 4-coccygeal) has four curves. Cervical and lumbar curves are convex 
anteriorly and thoracic & sacral curves are convex posteriorly. The curves of the 
vertebral column influences the spread of the local anaesthetic in the subarachnoid space. 
 Each vertebra is composed of a body separated from the adjacent vertebra by 
intervertebral disc and formed by pedicles and laminae, which surround and protect the 
cord laterally and posteriorly. 
    The vertebral column is bound together by several ligaments. They are, 
1. Supraspinal ligament – passes longitudinally over the tips of the spinous processes 
from C7 to the sacrum. 
2. Interspinous ligament – connects the adjoining spinous processes together.  
3. Ligamentum Flavum – composed of yellow elastic fibres known as yellow 
ligament, connects the adjacent laminae. They become progressively thicker from 
above downwards. 
4. Posterior longitudinal ligament – It is on the posterior surface of bodies of 
vertebrae. 
5. Anterior longitudinal ligament – It runs along the front of the vertebral bodies. 
Vertebral canal formed by these structures has deficiencies posteriorly in the 
midline called inter laminar foramina which enlarges in flexion is accessible for the 
passage of spinal needle. The direction of spinous process determine the direction of 
spinal needle. 
  
 
SPINAL CORD: 
 It is the direct continuation of the medulla oblongata extending from the upper 
border of the atlas to the first lumbar vertebra below which there is leash of nerve roots 
termed cauda equina. Spinal nerves are 31 pairs totally. 
 8  –  Cervical 
 12  –  Thoracic 
 5  –  Lumbar 
 5  –  Sacral 
 1  –  Coccygeal          
 Each of the spinal nerve is composed of anterior and posterior roots uniting at the 
inter vertebral foramina and form a nerve trunk. Membranes covering the spinal cord are 
dura mater, arachnoid mater and piamater. Dura and arachnoid mater end at S2 level. 
Piamater is closely adjacent to the spinal cord. 
BLOOD SUPPLY: 
 It is from the anterior spinal artery which is a branch of vertebral artery and also 
by a pair of posterior spinal arteries which arise from the posterior inferior cerebellar 
arteries. The anterior and posterior spinal arteries receive additional blood flow from the 
intercostals  arteries in the thorax and lumbar arteries.  One of these radicular arteries is 
typically large, the artery of Adamkiewicz. 
 
 
SPINAL VEINS: 
 The spinal veins are arranged into anterior and posterior plexus which are draining 
into vertebral, azygos and lumbar veins.        
 
 
CEREBROSPINAL FLUID: 
 This is an ultrafiltrate of the blood plasma from choroid plexus of the lateral 
ventricles with a pH of 7.32 (7.27-7.37) 
 It is a clear, colourless fluid found in the cranial and spinal subarachnoid spaces 
and in the ventricles of the brain. 
 The total volume of CSF in an average adult ranges from 120-150ml of which 25-
35ml is in the spinal subarachnoid space. 
Composition of cerebrospinal fluid: 
Specific gravity  - 1.006 (1.003-1.009) at 370C   
Pressure   - 60-80mm of water 
PCO2    - 48mmHg 
HCO3-   - 23meq/l 
Na+    - 133-145meq/l 
Ca+    - 2-3meq/l 
PO4-    - 1.6mg/dl 
Mg+    - 2-2.5mg/dl 
Cl-    - 15-20mg/dl 
Protein   - 23-38mg/dl 
Sugar    - 45-80mg/dl 
Lymphocytes  - 0-5cells/cmm 
 
 
 
BARICITY 
      Baricity  plays an important role in spread of local anaesthetic in the spinal 
space. Baricity of spinal anaesthetic solution is a ratio :  the density of local 
anaesthetic divided by  density of CSF both at 37 degree centigrade. Local 
anaesthetics can be hyperbaric ,hypobaric or isobaric, when compared to CSF.  
        The anesthetic solution is said to be hyperbaric when baricity  is more than 
1.008 gm/ml ,isobaric when baricity is  between 0.9980 – 1.0080 gm / ml, hypobaric 
when baricity is less than 0.9970 g / ml. Hyperbaric solutions are prepared by adding 
dextrose, isobaric is a plain drug, hypobaric by adding water. 
 Density Baricity 
Water 0.9933 0.9930 
CSF 1.0003 1.0000 
Isobaric 
  Lignocaine 2%  
  Bupivacaine 0.5%  
  Ropivacaine 0.5% 
 
1.0004 
0.9993 
0.9995 
 
1.0003 
0.9990 
0.9988 
Hyperbaric 
  Lignocaine 5% in dexrose7.5% 
Bupivacaine 0.5%with dextrose 8 %  
 
1.0265 
1.0210 
 
1.0265 
1.0207 
Hypobaric solutions are less dense than CSF and tend to rise against gravity 
which leads to   higher spread. 
Isobaric solutions are as dense as CSF and tend to remain at the level at which 
they are injected.  Cephalad movement is due to bulk movement of CSF which carries 
any drug injected intrathecally.Hyperbaric solutions are more dense than CSF and tend to 
follow gravity after injected.  So, positioning soon after performing the spinal 
anaesthesia is important. 
PHYSIOLOGY OF SUBARACHNOID BLOCK 
 Subarachnoid block implies the temporary interruption of nerve transmission 
within the subarachnoid space by injections of local anaethetics. The blockade of nerve 
fibres occur in the order of temperature, pain, proprioceptive and then motor fibres.   
 
FACTORS INFLUENCING HEIGHT OF BLOCKADE: 
a -  Site of injection  
b -  Angulation of needle  
c -  Characteristic of local anaesthetic - baricity 
d -  Dose of local anaesthetic 
e -  Position of the patient during and after injection 
f -  Anatomic configuration of spinal column. 
g -  Patient height (at extremes) 
h -  Volume of cerebrospinal fluid 
i -  Reduced cerebrospinal fluid with increased intra  
  abdominal  pressure (eg. Pregnancy) 
 
 
 
a) Effects on Cardio Vascular System:    
 Most important physiological response to subarachnoid block involve cardio 
vascular system due to combined effect of autonomic denervation, higher level of neural 
block, added effect of vagal innervation.  
 Local anaesthetics and vasoactive substances administered in small doses 
intrathecally leads to direct cardiovascular effect. Level of sympathetic denervation 
determines the magnitude of cardio vascular system responses, but the relationship is 
neither predictable nor precise. 
 Sympathetic denervation produces arterial and more physiologically important 
arteriolar dilatation and vasodilatation in the venous circulation produces fall in blood 
pressure. 
 Due to Bainbridge reflex, the fall in blood pressure is associated with bradycardia, 
blockade of cardiac sympathetic fibre from T1-T4 is an additional factor that causes 
bradycardia.  
b) Effects on Respiratory System: 
 Respiration is not depressed normally. Higher level blockade can cause paralysis 
of intercostals muscles but resting tidal volume, maximum inspiratory volume, 
respiratory rate, arterial blood gas, negative intrapleural pressure and also the phrenic 
nerve are unaffected. Hypoxia may accompany hypotension and is corrected by oxygen 
administration via face mask. 
c) Gastro Intestinal Effect: 
 Preganglionic fibres from T5-L1 are inhibitory to gut. So in sympathetic blockade 
the small intestine contracts with relaxed sphincters and peristalsis remains normal. 
Handling of viscera causes discomfort and bradycardia since vagus is not blocked. 
d) Hepatic and Renal Effects: 
 The hepatic blood flow decreases and is directly proportional to the decrease in 
blood pressure. There may be normal hepatic oxygen extraction. Renal blood flow is 
maintained by autoregulation and does not decrease till mean arterial pressure goes 
below 50mmHg. 
e) Genito Urinary System:           
 Sphincters of bladder are not relaxed, and tone of the ureter is not greatly altered. 
Urinary retention occurs. Penis is often engorged. Uterine tone is unchanged in 
pregnancy. In the absence of hypotension spinal anaesthesia has got no effect on the 
progress of labour and uterine blood flow.  
 
 
f) Metabolic and hormonal effect: 
 Spinal anaesthesia blocks hormonal and metabolic responses to nociceptive 
stimuli arising from the operative site. It minimizes the rise in blood sugar, cortisol, 
catecholamines, renin and aldosterone release associated with stress. Post operative 
negative nitrogen balance and secretion of antidiuretic hormone are inhibited.  
g) Thermo Regulation: 
 Hypothermia results from heat loss to the cold environment due to vasodilatation. 
 
 
 
 
 
  
 
 
 
 
 
 
 
STRUCTURE OF BUPIVACAINE 
 
 
 
 
 
 
 
 
THREE DIMENSIONAL VIEW OF BUPIVACAINE - MOLECULE 
 
 
 
 
 
 
 PHARMACOLOGY OF DRUGS 
a) Bupivacaine: 
 Bupivacaine is an amide linked local anaesthetic. It is a hydrochloride salt of d(1)-
1-butyl N-(2’6’ dimethylphenyl) piperidine – 2 - carboxamide and is presented as a 
racemic mixture. 
¾ It was synthesized by Ekenstem. 
¾ First reports of its use was published in 1963 by Telivuo. 
¾ It is derived from Mepivacaine and is very stable compound and may be 
autoclaved repeatedly. 
Pka      -  8.1 
MW     -  288  
Protein binding    -  95% 
Lipid solubility   -  28 
Elimination half life  -  210 minutes 
Toxic plasma concentration -  >1.5μg/ml 
Approximate duration of action-  175minutes 
Availability: 
 Available in ampoules of 0.5% Bupivacaine hydrochloride and  0.5% Bupivacaine 
hydrochloride with dextrose (heavy). 
 Vials- 0.25% and 0.5% Bupivacaine hydrochloride. 
 Dosage - Maximum dosage 3mg/kg body weight. 
Uses: 
¾ Spinal anaesthesia 
¾ Epidural anaesthesia 
¾ Caudal anaesthesia 
¾ Continuous epidural anaesthesia 
¾ Peripheral nerve block 
Onset time and duration of action 
Site of action Onset (minutes) Duration (minutes) 
Intrathecal  5 180-240 
Epidural 15-20 165-225 
Brachial plexus 15-20 600 
 
Pharmacokinetics: 
 Once injected intrathecally, it gets absorbed by the nerve rootlets and results in the 
desired effect. It is rapidly absorbed from the site of injection, but the rate of absorption 
depends on the vascularity at the site and presence of vasoconstrictors. 
 High lipid solubility of Bupivacaine makes it easy for nerve and vascular tissue 
penetration. 
 80-95% of the absorbed Bupivacaine binds to the plasma. 
Distribution: 
 Rapid distribution phase: (α) 
 In this phase the drug is distributed to highly vascular region t1/2 of α  - being 2.7 
minutes.      
 Slow disappearance phase: (β) 
 In this phase the drug distributes to slowly equilibrating tissues t1/2 of β – being 
28minutes.  
 Biotransformation and excretion phase δ  
 T1/2 of δ is 3.5hours and clearance is 0.47 litre/minute. 
Biotransformation: 
 Possible pathways of metabolism of Bupivacaine include aromatic hydroxylation 
and conjugation. Only the N-dealkylated metabolite, N-desbutyl Bupivacaine has been 
measured in blood (or) urine after epidural (or) spinal anaesthesia. Alpha-1 acid 
glycoprotein is the most important plasma protein binding site of Bupivacaine and its 
concentration is increased by many clinical situations including post operative trauma. 
Excretion: 
 4-10% of the drug is excreted through the kidneys. 
 
Mode of Action: 
a) Site of action: 
i) The spinal nerve rootlet fine nerve filaments having a large surface area are 
exposed to the local anaesthetics.  
ii) Posterior and lateral aspects of the spinal cord itself. 
b) Sodium Channel blockade: 
 They impede sodium ion access to the axon interior by occluding the 
transmembrane sodium channels thus delaying the process of depolarisation and axon 
remains polarized. It is a non-depolarisation blockade.     
Pharmacodynamics: 
 It has got a longer duration of action but a slower onset. 
Cardio vascular system: 
 It reduces cardiac output by reducing the sympathetic tone, by slowing the heart 
rate and by reducing the venous return, it produces a fall in arterial blood pressure but it 
is relatively slow and is seldom very profound. 
 It produces a fall in central venous pressure. It causes an increase in lower limb 
blood flow and reduction in incidence of deep vein thrombosis. 
Respiratory System: 
 Spinal blockade seldom, if ever causes respiratory problem. 
Gastro intestinal tract: 
 There is an increase in gastro intestinal motility and emptying of the gastric 
contents are better.   
 Toxicity: 
 Toxicity is related to plasma level of unbound drug and more likely due to an 
inadvertent intravenous injection. Systemic toxicity reactions primarily involve central 
nervous system and cardio vascular system. The blood level required to produce central 
nervous system toxicity is less than that required to produce circulatory collapse.  
Central Nervous System Toxicity:    
 Initial symptoms  include  feeling of light headedness and dizziness, followed by 
visual and auditory disturbances. Objective signs are excitatory and includes shivering, 
muscle twitching and tremor. Ultimately generalized tonic, clonic seizures occurs. 
Cardiovascular System Toxicity: 
       The rate of depolarization in fast conducting tissue of purkinje fibres and ventricular 
muscle is decreased. The rate of recovery of Bupivacaine induced block is slower than 
that of lignocaine. Extremely high concentration of the drug causes sinus bradycardia 
and cardiac arrest. 
 
  
 
 
 
STRUCTURE OF ROPIVACAINE 
 
 
 
 
 
 
 
 
 
THREE DIMENSIONAL VIEW OF ROPIVACAINE – MOLECULE 
 
 
 
 
 
 
 
 
  
 
 
ROPIVACAINE 
 Ropivacaine is a pure S-enantiomer of propivacaine, a long acting amide local 
anaesthetic.  It is a hydrochloride salt of (S) – N – C2, 6 – dimethylphenyl – 1- 
propylpiperidine 2- carboxamide. 
 It was simultaneously synthesized with Bupivacaine by Ekenstem 
 It was first launched in 1996. 
 pKa    -  8.1 
 MW      -   328.89 
 Protein binding    -  94% 
  Solubility     - 53.8mg/ml in water.  
Toxic plasma  concentration >4 micro gram/ml. 
Clearance   - 44L/min. 
Availability : 
Available in ampoules as isobaric solution in concentrations of  0.2%, 0.5% and 
0.75% 
Dosage : Maximum dosage 3 mg / kg body weight 
Uses : 
• Spinal anesthesia 
• Epidural anaesthesia 
• Caudal anaesthesia 
• Continuous epidural anaesthesia 
• Peripheral nerve blocks 
 Conc.% Volume (ml) Onset of action 
(minutes) 
Spinal 0.5% 
0.75%  
3 – 4 
3 – 4 
4 – 5 
Epidural 0.2% 
0.5% 
0.75% 
15 – 20 ml 15 – 20 
Caudal 0.2 % 1ml / kg 10 - 15 
Peripheral block 0.5% 
0.15% 
15-30 15 
 
Pharmacokinetics : 
Once injected intrathecally it gets absorbed by the nerve rootlets and results in 
desired effect. 
It is low lipid soluble when compared to Bupivacaine; it is 94% protein bound, 
mostly to alpha-1 acid glycoprotein. 
The effect of Ropivacaine on peripheral vascularity is biphasic; it causes 
vasoconstriction at concentration < 0.50%, vasodilatation in concentration>1%. 
Distribution : 
 It does not need adrenaline to prolong the duration  of action. 
 The mean t ½ of initial phase is 14 min. 
 Then t ½ of slower phase  is 4.2 hrs. 
 Clearance from epidural infusion  0.75% 5L / hr. 
       0.5%  10L /hr. 
 
 
Biotransformation : 
 Ropivacaine is metabolized in liver by aromatic hydroxylation to 3- hydroxy 
Ropivacaine by cytochrome (CYP) 1 A2 and N- deakylation to  
2’, 6’  pipecoloxylidide by CYP 3A4.  Other metabolites include 
   L’-Hydroxy Ropivacaine  and   2’-Hydroxy methyl Ropivacaine. 
Excretion : 
 80% of the drug is excreted through kidneys. 
Mode of action : 
a)  Site of action is on the spinal nerve rootlet fine  nerve filaments  and posterior and 
lateral aspects of the spinal cord itself. 
b)  Mechanism of action 
 Blocks   impulse conduction in  nerve fibres via reversible inhibition of sodium 
ion influx. 
 
Pharmadynamics : 
 It has slower onset and short duration when compared with Bupivacaine. It  
blocks sensory fibres  more than motor fibres. High Pka and low lipid solubility favours 
the blockade of unmyelinated C  and A delta fibres which blocks the pain and 
temperature sensations  predominantly. 
Cardiovascular system : 
 It reduces cardiac output by reducing the sympathetic tone, by slowing the heart 
rate and by reducing the venous return. It also produces fall in arterial blood pressure but 
is relatively slow and less profound, when compared  to Bupivacaine. 
Respiratory system : 
 Spinal blockade with Ropivacaine seldom causes respiratory problem. 
Toxicity : 
 Toxicity is related to plasma levels of unbound drug and is due to inadvertant 
intravenous injection or due to increased drug dosage (>3mg/kg).  Ropivacaine causes 
more central nervous system toxicity than cardiovascular toxicity.  Since Ropivacaine is 
a pure S-enantiomer it has less affinity for the cardiac  sodium channels, hence less of 
cardiotoxicity.It has less volume of distribution when compared to Bupivacaine.All these 
features reduce the potency, but  reduces the cardiotoxicity and central nervous system 
toxicity. 
Cardiovascular toxicity: 
Extreme high concentrations cause bradycardia and cardiac arrest. 
Central nervous system toxicity : 
 Initial symptoms  include  feeling of light headedness and dizziness, followed by 
visual and auditory disturbances.  Signs are excitatory including shivering, muscle 
twitching and tremor, finally leading to generalized tonic, clonic seizures. 
Drug  interactions : 
  The CYP1A2 inhibitors fluroxamine and ciprofloxacin significantly reduce 
the plasma clearance of Ropivacaine by 77% and 31% respectively. 
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MATERIALS AND METHODS 
 
This study was done in 100 patients who are divided into two groups, after getting 
approval  from the Ethical Committee. Written informed consent was taken from all 
patients. It is a prospective randomized double blinded study. 
100 patients were randomly allocated into two groups 50 each 
 Group B -  received isobaric Bupivacaine 0.5% 3 ml(15 mg) 
 Group R -  received isobaric Ropivacaine 0.5% 3 ml(15 mg) 
Inclusion Criteria : 
 ASA I & II patients 
 Age 20 – 60 years, Height  : 150 – 170 cms 
 Patients  undergoing elective lower limb and perineal surgeries with duration less 
than 2 hrs. 
Exclusion criteria are 
• Patient refusal 
• ASA III & IV  
• Morbidly  Obese patients 
• Patients with neurological disease 
• Spinal deformity 
• Drug allergy to local anaesthetics 
• Any other contraindication for regional technique 
Preoperative preparation : 
 Routine pre operative assessment as for all elective surgery . 
 Premedicated with Inj. Pentazocine  0.6mg/kg and Glycopyrollate 0.005mg/kg 
given intramuscularly 45 minutes before surgery. 
 Name, IP No., Age, Sex, Weight, Height, ASA, Diagnosis, type of surgery  and 
duration of surgery were recorded. 
Procedure Details : 
Monitors are connected to the patient and the baseline values of pulse rate, systolic 
and diastolic blood pressure and oxygen saturation were noted. IV cannula inserted ; 
Ringer lactate infusion started.  
Under strict aseptic precautions, after infiltration of skin with 1% lignocaine, 
subarachnoid block was performed in the sitting position in L3-L4 interspace with a 25 
gauge Quincke’s needle.  
After ensuing free flow of CSF, the drug was injected. After injection, patients were 
put up in supine position. After attaining adequate level of sensory block, the surgeons 
were asked to proceed with the surgery. 
Parameters recorded : 
1.  Hemodynamic parameters : 
a) Pulse rate, non invasive blood pressure and oxygen saturation were 
monitored every 2 minutes for the first 10 minutes and every 5 minutes till 
1hour and every 15 minutes till the end of surgery. 
b) Any decrease in mean arterial pressure 20% from the baseline or less than 
90mm of systolic pressure was treated with a bolus of ephedrine (6 mg). 
c) Any decrease in pulse rate less than 60/min was treated with atropine 0.6 mg. 
 
 
2.  Sensory blockade: 
 Sensory blockade was assessed by pin prick in the mid axillary line at 1 min 
interval until the level of block reached L1.  The maximum height of the sensory 
blockade was noted. 
 Onset of sensory block was defined as the time taken from injection of drug to 
sensory block at L1 and   offset of sensory block was assumed when pinprick sensation 
at the S 5 dermatome has returned. Duration of sensory block was defined  as the time 
interval between onset of sensory block at L1 to regression of  sensory block to S5. 
3 . Motor blockade : 
 Motor block was assessed by the Modified Bromage score. 
 0 - No motor loss 
 1 - Inability to flex hip 
 2 - Inability to flex knee joint 
 3 - Inability to flex ankle 
 This is assessed at 1 min interval until complete motor blockade occured.  Onset 
of motor block was defined as the time taken from injection of drug to development of 
complete motor block.  (Bromage Score-3). Bromage score ‘0’ was considered as 
complete recovery from motor block.  Duration of motor block was defined as time taken 
from onset of complete motor block to complete recovery of motor block. 
4. The highest dermatomal level of sensory block was noted. 
5. Time taken to achieve the highest dermatomal level was noted. 
6. Two segment regression time (ie. The time taken to decrease from maximum sensory 
level by two segments from initial level) was noted. 
7. Quality of block was graded as adequate – no sedation / analgesia required, 
Inadequate – need for additional analgesia, failed – GA required.  If the level of 
analgesia was inadequate or failed the regimen was switched to GA and excluded from 
the study. 
8. Time of micturation was noted. 
9. Duration of surgery were noted. 
Statistical Tools : 
The information collected regarding all the selected cases were recorded in   Master 
Charts  1 and 2 .Data analysis was done with the help of computer using Epidemiological 
Information Package (EPI 2008).  
 Using this software range, frequencies, percentages, means, standard deviations, chi 
square and  'p'  values were calculated. Kruskul Wallis chi-square test  was used to test the 
significance of difference between quantitative  variables  and Yate’s test  for qualitative 
variables. A 'p' value less than 0.05 is taken to denote significant relationship. 
 
 
 
  
 
OBSERVATION AND RESULTS 
In this randomized double blinded  study conducted in 100 patients, the subjects 
were allocated into 2 groups, 
Group B ;Isobaric Inj.Bupivacaine 0.5% - 3 ml(15 mg) 
Group R ;Isobaric Inj. Ropivacaine 0.5% -3ml(15 mg) 
All  the  parameters recorded  are  tabulated  and  analysed.  
Table  1 :  Age distribution 
Age 
group(yrs) 
Group B Group R 
No. % No. % 
20- 30  9 18 14 28 
31-40 17 34 11 22 
41-50 13 26 15 30 
>50 11 22 10 20 
Total 50 100 50 100 
Range 
Mean 
SD 
20-60 yrs 
40.84 
10.42 
20-60 yrs 
39.76 
12.41 
‘p’ value  0.638  Not significant 
  
The mean age are comparable and they are not statistically significant. 
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Table  2:  Sex distribution 
 
Sex distribution Group B Group R 
No. % No. % 
Male 41 82 40 80 
Female 9 18 10 20 
Total 50 100 50 100 
‘p’ value  0.542 Not significant 
 
 The sex distribution are comparable and they are not statistically significant.                              
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Table 3  : Height(cms) 
 
Height (cm) Group B Group R 
No.of cases % No.of cases % 
150 – 160 30 60 23 46 
161 – 170 20 40 27 54 
Range 150-170 150-170 
Mean 159.8 161.72 
SD 6.21 5.22 
‘p’ value for 0.097 Not significant 
 
The mean height in both the groups are comparable and they are not statistically 
significant. 
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Table 4  : Weight(kg) 
Weight(kg) Group B Group R 
Range 45-75 50.70 
Mean 59.04 60.48 
SD 5.86 5.36 
‘p’ value  0.203  not significant 
 
In both groups the weights  are comparable they are not statistically significant 
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TABLE - 5 :   ASA Physical status 
ASA  risk Group B Group R 
No. % No. % 
I 46 92 46 92 
II 4 8 4 8 
‘p’ value  1.000   Not significant 
 
 The ASA physical status are comparable and they are not statistically significant. 
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Table - 6  : Onset of Sensory Block (minutes) 
Onset of 
Sensory 
Block(min) 
Group B 
 
Group R 
 
Range 2 – 5 4 – 8 
Mean 3.32 6.40 
SD 0.741 0.948 
‘p’ value  < 0.001 significant 
 
 In Group B the mean onset  of sensory block is 3.32minutes. 
In Group R the mean onset of sensory block is 6.40minutes. 
The mean onset of sensory block is delayed in Ropivacaine when compared to 
Bupivacaine and is statistically significant. 
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Table - 7  : Maximum Sensory Level 
Maximum 
Sensory Level 
Group B Group R 
No. % No. % 
T4 4 8 0 0 
T5 8 16 0 0 
T6 23 46 0 0 
T7 12 24 0 0 
T8 3 6 7 14 
T9 0 0 6 12 
T10 0 0 26 52 
T12 0 0 11 22 
 
In Group B the maximum sensory level ranges from T4-T8 and in 46%  of cases   
the maximum level reached  is  T6 .  
In Group R the maximum sensory level ranges from T8-T12 and  in 52% of cases the 
maximum level reached  is T10. 
Ropivacaine reaches a low sensory level when compared to Bupivacaine. 
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Table - 8  : Time taken to reach the Max. sensory height (min) 
 
Time to reach 
maximum sensory 
level(min) 
Group B Group R 
Range 12 – 16 12 -18 
Mean 14.26 14.76 
SD 0.944 1.302 
‘p’ value  0.060  Not Significant 
 
In Group B the time taken to reach the highest sensory level is 14.26 minutes. In 
Group R the time taken to reach  the highest sensory level is 14.76 minutes. Both groups 
are comparable and it not statistically significant. 
 
 
 
 
 
 
 
  
 
 
 
 
14.26
14.76
12
12.5
13
13.5
14
14.5
15
15.5
16
M
E
A
N
Group B Group R
Time taken to reach the Max. sensory height (min)
 
 
 
 
 
 
 
 
  
 
 
 
Table -9  : Two segment Regression Time (minutes) 
Two segment 
regression time(min) 
Group B 
 
Group R 
Range 75 – 155 45 – 165 
Mean 97.9 63.7 
SD 11.48 21.02 
‘p’ value  < 0.001significant 
 
In group B, the mean value of time taken for two segment regression   is 97.9 
minutes.  In group R, the mean value of time taken   for two segment regression  is 63.7 
minutes.  The two segment  regression  time is  shorter for Ropivacaine than Bupivacaine 
and is  statistically significant. 
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Table -10  : Onset of Motor block (min) 
 
Onset of motor 
block(min) 
Group B Group R 
Range 3 – 7 8 – 12 
Mean 4.70 9.40 
SD 0.886 1.069 
‘p’ value  < 0.001significant 
  
 In Group B the mean onset of motor block is 4.70 minutes. 
In Group R the mean onset of motor block is 9.40 minutes .The onset of motor block of 
Ropivacaine is delayed when compared to Bupivacaine  and is statistically significant. 
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Table - 11  : Duration of Sensory Block (min) 
Duration of 
Sensory Block 
Group B 
 
Group R 
Range 180-245 120-190 
Mean 219.9 162.9 
SD 17.04 15.55 
‘p’ value  < 0.001significant 
 
In  Group B the mean duration of sensory block is 219.9 minutes. 
In Group R the mean duration of sensory block is 162.9 minutes. 
The duration of sensory block  is shorter for Ropivacaine  compared with Bupivacaine  
and is statistically significant. 
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Table - 12  : Duration of Motor Block(min) 
 
Duration of 
Motor 
Block(min) 
Group B 
 
Group R 
Range 165-235 100-175 
Mean 203.8 142.9 
SD 17.16 14.61 
‘p’ value  
 
< 0.001 Significant 
 
In Group B the mean duration of  motor block is 203.8.minutes. 
In Group R the mean duration of motor block is 142.9minutes. 
The duration of motor block is shorter for  Ropivacaine   when compared to Bupivacaine 
and is statistically significant. 
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Table – 13   Quality of Block 
 
Adequate Group B Group R 
No. % No. % 
Yes 0 0 0 0 
No 50 100 50 100 
 
The quality of block was adequate in both groups 
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Table - 14  : Time of micturation (in Minutes) 
 
TIME OF 
MICTURATION 
Group B 
 
Group R 
Range 260-340 200-270 
Mean 319.0 240.8 
SD 16.93 14.55 
‘p’ value  
 
< 0.001 Significant 
 
In Group B the time taken to micturate is 319 minutes. In Group R the time taken to 
micturate is 240.8 minutes.The time taken to micturate is shorter for Ropivacaine 
compared with Bupivacaine and is statistically significant. 
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Table  15 :    FALL IN PULSE RATE (%) 
 
FALL IN  
PULSE RATE 
Group B Group R 
No. % No. % 
Yes 14 28 3 6 
No 36 72 47 94 
‘p’ value 0.003  Significant 
 
In group B, 28% of cases had bradycardia and in Group R, 6% of cases had 
bradycardia  (less than 60/min), which is significant. 
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 Table 16 : PULSE RATE(per min) 
PULSE 
RATE 
Group B Group R P value 
Mean SD Mean SD 
Pre op 83.22 9.09 81.44 0.283 0.283Not significant 
2 min 82.24 9.03 80.12 0.195 0.195Not significant 
4 min 81.88 8.51 79.10 0.063 0.063Not significant 
6 min 79.06 8.46 80.40 0.564 0.564Not significant 
8 min 79.06 8.39 80.26 6.18 0.418Not significant 
10 min 76.32 8.96 78.50 8.10 0,205Not significant 
15 min 75.26 7.51 78.120 8.26 0.073Not significant 
20 min 72.12 7.658 77.62 10.03 0.063Not significant 
25 min 70.70 9.19 77.66 10.25 0.001 Significant 
30 min 73.10 10.08 80.08 10.69 0.001 Significant 
35 min 76.3 10.94 82.32 11.45 0.042 Significant 
40 min 77.46 10.12 82.04 11.76 0.064Not significant 
45 min 78.74 10.18 78.76 10.20  0.074Not significant 
50 min 80.22 11.21 81.13 10.59 0.074Not significant 
55 min 80.85 11.60 80.54 11.46 0.082Not significant 
60 min 83.86 11.45 84.83 10.60 0.404Not significant 
75 min 84.67 16.16 87.33 10.58 0.744Not significant 
 
Fall in pulse rate occured between 25 to 35 minutes which is significant.  
 
 
 
 
 
  
 
 
Table  17 :    FALL IN SYSTOLIC BP  
 
FALL IN 
SYSTOLIC BP 
Group B Group R 
No. % No. % 
Yes 14 28 3 6 
No 36 72 47 94 
‘p’ value 0.003  Significant 
 
In group B, 28% of cases had fall in systolic BP and  in Group R, 6% of cases had  
fall in systolic BP, which is significant. 
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Table 18: Systolic Blood Pressure(mm of Hg) 
Systolic 
B.P. 
Group B Group R P value 
Mean SD Mean SD 
Pre op 123.9 8.12 121.76 7.06 0.163 Not significant 
2 min 121.4 17.52 121.4 6.21 1.000 Not significant 
4 min 121.88 7.003 120.36 5.78 0.239 Not significant 
6 min 119.56 7.93 118.68 5.95 0.532 Not significant 
8 min 116.84 8.26 117.6 5.84 0.597 Not significant 
10 min 113.72 7.65 115.18 7.03 0.323 Not significant 
15 min 111.50 9.67 112.68 6.43 0.474 Not significant 
20 min 110.10 10.005 111.84 6.77 0.311 Not significant 
25 min 107.8 6.31 110.12 5.89 0.032 Significant 
30 min 109.96 6.95 110.8 4.67 0.025 Significant 
35 min 111.78 7.71 110.52 4.77 0.014 Significant 
40 min 113.88 8.80 111.56 6.44 0.136 Not significant 
45 min 116.38 13.32 112.4 6.99 0.064 Not significant 
50 min 115.95 8.35 114.85 6,14 0.490 Not significant 
55 min 118.26 7.87 116.56 6.016 0.320 Not significant 
60 min 121.18 6.81 118.13 5.73 0.164 Not significant 
75 min 124 6.93 123.3 4.27 0.829 Not significant 
 
The fall in systolic BP occured between 25 to 35 minutes which is  significant.  
 
 
 
 
 
  
Table  19 :    FALL IN DIASTOLIC BP 
 
FALL IN 
DIASTOLIC BP 
Group B Group R 
No. % No. % 
Yes 14 28 3 6 
No 36 72 47 94 
‘p’ value 0.003  Significant 
 
In group B, 28% of cases had fall in diastolic BP and  in Group R, 6% of cases 
had fall in diastolic BP ,which is significant. 
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Table 20 : Diastolic Blood Pressure(mm of Hg) 
Diastolic 
B.P. 
Group B Group R P value 
Mean SD Mean SD 
Pre op 79.28 4.48 79.08 3.92 0.813 Not significant 
2 min 79.16 4.58 79.04 3.82 0.887 Not significant 
4 min 78.30 4.93 78.84 3.86 0.543 Not significant 
6 min 77.20 4.40 77.80 4.43 0.499 Not significant 
8 min 75.96 5.15 77.56 4.39 0.098 Not significant 
10 min 74.92 6.78 76.92 5.18 0.068 Not significant 
15 min 73.40 7.04 75.90 5.99 0.066 Not significant 
20 min 72.38 5.81 75.52 5.02 0.005  significant 
25 min 71.80 6.88 74.62 5.72 0.025  significant 
30 min 72.70 5.89 74.44 3.45 0.037  significant 
35 min 73.60 5.24 73.68 4.03 0.932 Not significant 
40 min 74.92 5.05 73.34 3.39 0.084 Not significant 
45 min 74.80 5,16 73.16 4.35 0.089 Not significant 
50 min 75.70 6.75 73.55 5.01 0.073 Not significant 
55 min 75.66 4.54 74.56 4.26 0.296 Not significant 
60 min 75.73 4.24 76.0 3.67 0.834 Not significant 
75 min 79.0 3.83 78.5 2.07 0.770 Not significant 
 
The fall in diastolic BP occured between 20 to 30 minutes which is  significant.  
 
 
 
  
 
 
Table No.    21   Oxygen saturation in % 
 
 
Oxygen saturation 
in % 
Group B 
 
Group R 
Range 98-100 98-100 
Mean 99.26 99.26 
SD 0.694 0.664 
‘p’ value  
 
P = 1.000  
Not Significant 
 
 The oxygen saturation is comparable in both groups. It is not statistically 
significant. 
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Table  22 :    Use of Atropine 
Use  of 
Atropine 
Group B Group R 
No. % No. % 
Yes 14 28 3 6 
No 36 72 47 94 
‘p’ value 0.003  Significant 
 
Atropine is used in 28% of cases in Group B and 6% of cases in Group R. 
Atropine is used less in Ropivacaine group compared to Bupivacaine group and is 
statistically significant. 
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Table  23    Use of Vasopressor 
Use of 
Vasopressor 
Group B Group R 
No. % No. % 
Yes 14 28 3 6 
No 36 72 47 94 
‘p’  value 0.003  Significant 
 
Vasopressor is used in 28% of cases in Group B and 6% of  cases  in Group R.  
Vasopressor is used less in Ropivacaine group compared to Bupivacaine  group and is 
statistically significant. 
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DISCUSSION 
Hyperbaric Bupivacaine is  commonly used intrathecally for lower limb and 
perineal surgeries.  The newly introduced Ropivacaine have evolved a history in spinal 
anaesthesia because of its short duration of action and quality of anesthesia for surgeries 
of short duration. 
 Ropivacaine, because of its differential blockade, is used in epidural labour 
analgesia and in epidural post operative analgesia. 
 In isobaric drug, gravity has no effect on the distribution.  The upper level of 
sensory block was two segments higher in hyperbaric and hypobaric than isobaric 
solutions. So possibly fewer segments are blocked, limiting the extent of sympathetic 
block and hence more of hemodynamic stability. 
 In this study isobaric Bupivacaine and isobaric Ropivacaine at equal doses (15 
mg)are given intrathecally for lower limb surgeries and perineal surgeries of short 
duration. 
Onset of sensory block : 
 In this study, onset of sensory block at L1 is 6.4 minutes for Ropivacaine group 
and3.32minutes for Bupivacaine group. This delay is due to the lower lipid solubility of 
Ropivacaine when compared to Bupivacaine.  A Mehta, V. Gupta and collegues studied 
in 75 patients and concluded that the onset of sensory level is delayed in Ropivacaine 
than Bupivacaine, which is similar to this study. 
Maximum sensory level (Dermatome) 
 In this study, the maximum sensory level ranges from T8-T2 in Ropivacaine 
group and T4 – T8 in Bupivacaine group.  Since more segments are blocked in 
Bupivacaine group, the extent sympathetic block is more and there is more of 
hypotension and bradycardia in Bupivacaine group compared to Ropivacaine group. 
Hence vasopressors and atropine are used more in Bupivacaine group than Ropivacaine 
group.  So Ropivacaine is more of hemodynamically stable than Bupivacaine.  M. 
Montouvalou and collegues conducted a study and concluded that maximum sensory 
level reached is higher for Bupivacaine than Ropivacaine, which is similar to this study. 
Time taken to reach the highest dermatome : 
 In this study, Ropivacaine took 14.76 minutes, when compared to 14.26 minutes 
for Bupivacaine.  There is no marked difference in both.  In studies of Malinovsky, 
Charles and collegues, they concluded that the time taken to reach the highest dermatome 
is same in both Ropivacaine and Bupivacaine ,which is similar to this study . 
Two segment regression time : 
 In this study, two segment regression time in Ropivacaine group was 63.7 minutes 
and Bupivacaine group was 97.9 minutes. The two segment regression time is shorter for 
Ropivacaine when compared to Bupivacaine. 
Onset of motor block : 
 In this study, onset of motor block is 9.40 minutes in Ropivacaine group and 4.70 
minutes in Bupivacaine group. The onset of motor block is delayed in Ropivacaine when 
compared to Bupivacaine.  A.Mehta V.Gupta and collegues conducted a study and 
concluded that onset of motor block is delayed in Ropivacaine when compared to 
Bupivacaine, which is similar to this study. 
Duration of sensory block : 
 In this study, the duration of sensory block is 162 .9 minutes in Ropivacaine and 
219 minutes for Bupivacaine group.  The duration of sensory block is shorter in 
Ropivacaine  than Bupivacaine.  Hence  Ropivacaine is an ideal drug for ambulatory 
surgeries.  A.Mehta V.Gupta and collegues and the study by Gautier et al concluded that 
duration of sensory block is shorter for Ropivacaine than Bupivacaine, which is  
comparable with this study.  
 
Duration of motor block : 
 In this study, the duration of motor block is 142.9 minutes in Ropivacaine group 
when compared to 203.8 minitues in Bupivacaine group.  The duration of motor block is 
shorter for Ropivacaine than Bupivacaine, making it an ideal drug for ambulatory 
surgeries.  Neval Boztug and Zekiye Biget and collegues conducted a study and 
concluded that the duration for motor block is shorter for Ropivacaine than Bupivacaine 
making it an ideal drug for ambulatory surgeries. 
 
Time of Micturation : 
 In this study time taken to urinate for the first time after block was 240.8 minutes 
in Ropivacaine group and 319 minutes for Bupivacaine group, making it an ideal drug 
for ambulatory surgery, since patients can be discharged earlier.  Neval Boztug and 
Zekiye Biget and collegues conducted a study and concluded that the time taken for 
micturation is shorter for Ropivacaine than Bupivacaine, making it an ideal drug for 
ambulatory surgeries. 
 
 
Quality of Block : 
 In this study, quality of block was adequate in both groups.  Hence Ropivacaine is 
a good alternative to Bupivacaine for lower limb and perineal surgeries. 
Stuides conducted by McChelland, Mc Namee and collegues showed that quality of 
block was adequate both with  Ropivacaine and Bupivacaine groups, which is similar 
with this study. 
Hemodynamics : 
1.  Pulse rate : 
 In this study  bradycardia  occurred in 28% of cases in Bupivacaine group and 6% 
of cases in Ropivacaine group and treated with atropine 0.6 mg. Bradycardia occured 
between 25-35 minutes.  Hence Ropivacaine is hemodynamically stable than 
Bupivacaine. Use  of Atropine was less in Ropivacaine group than Bupivacaine group. 
2. Blood pressure : 
 In this study fall in B.P occurred in 28% of cases in Bupivacaine group and 6% of 
cases in Ropivacaine group and treated with ephedrine 6.0 mg.Fall in B.P occurred 
between 25-35 minutes.Use of Ephedrine was less with Ropivacaine group than 
Bupivacaine group.  Hence Ropivacaine is hemodynamically stable than Bupivacaine. 
Montouvalou , 
 Kalli and collegues conducted a study and has noted high incidence of hypotension in 
Bupivacaine group than Ropivacaine group, which is similar to this study. 
3.   Oxygen saturation : 
 In this study, oxygen saturation maintained the same as preoperative level, 
through out the surgery in both Bupivacaine and Ropivacaine groups.   
 
 
 
  
SUMMARY 
This randomized double blind study was conducted in 100 patients, aged 20-60 
years with height 150-170 cms with ASA I and II.  In groupB, 3 ml of isobaric 0.5% 
Bupivacaine is given intrathecally and in Group R 3 ml of isobaric 0.5% Ropivacaine.  
Parameters such as onset of sensory block L1, maximum dermatome of sensory block, 
time to reach the maximum height  of sensory block, two segment regression time, 
duration of sensory block, onset and offset of motor block, time of micturation and 
quality of block were observed.  Pulse rate, blood pressure and oxygen saturation were 
monitored. The usage of vasopressors and atropine were noted. 
Ropivacaine  significantly  delayed  the onset of motor and sensory block. But 
two segment regression, offset of sensory and offset of motor block, time of micturation 
were earlier than Bupivacaine. The quality of block was adequate in both groups. 
In group R, the hemodynamics  were stable compared with GroupB and use of 
vasopressors and atropine were less with Ropivacaine than Bupivacaine. There were no 
changes in oxygen saturation in both groups.  
  
 
 
 
 
 
 
  
 
 
 
CONCLUSION 
 
Intrathecal Ropivacaine delayed the onset of sensory and motor block; 
lowered the level of sensory block; shortened the duration of motor and sensory 
block, two segment regression time and time of micturation; with stable 
hemodynamics, than Bupivacaine.  
Ropivacaine  is an  ideal drug for ambulatory anesthesia and a good 
alternative to Bupivacaine for surgeries of short duration. 
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 PROFORMA 
 
Name  :      Date  : 
Age  :      Sex : 
IP No. :      Ht      :  Wt : 
ASA  : 
Diagnosis :      Surgery : 
Drug  : 
Premedication: 
Spinal Needle guage :     Interspace : 
        Posture     : 
Onset of sensory 
block (Time of 
injection to 
sensory block  
at L1) 
Max. 
height of 
sensory 
block  
Time to 
reach 
max.height 
Onset of motor 
block (Time of 
injection to 
complete 
motor block) 
Time of 2 
segment 
regression 
Offset of 
sensory 
level at 
S5 
Duration of motor 
block (onset of 
complete block to 
offset of motor block–
Bromage 0) 
Time of 
mictu 
ration 
 
 
 
 
 
 
       
 
Hemodynamics 
Time Heart Rate NIBP SPO2 Vasopressor (Ephedrine 
in mg) 
Atropine in 
mg 
Pre op      
2 min      
4 min      
6 min      
8 min      
10 min      
15 min      
20 min      
25 min      
30 min      
35 min      
40 min      
45 min      
50 min      
55 min      
60 min      
75 min      
90 min      
 
Duration of Surgery   : 
Duration of sensory block   : 
Duration of Motor block  : 
Quality of Block   : 
Time  of  micturation                  : 
If Ephedrine used, Dose  : 
If Atropine used, Dose  : 
Other complications  : 
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1 MUNEESWARAN 26347 
LL wound debrima 
with AB beading B 39 M 160 60 1 NO NO 3 T6 14 5 105 190 175 ADQ 320 75 
2 ARUMUGAM 29911 Hemaroidectomy B 35 M 162 55 1 NO NO 4 T6 14 6 100 220 210 ADQ 330 60 
3 SHARIF 29936 Hemaroidectomy B 41 M 155 60 1 NO NO 3 T7 15 5 90 230 215 ADQ 320 55 
4 VELMURUGAN 26945 LL  Raw area SSG B 34 M 160 52 1 NO NO 4 T6 13 6 95 185 170 ADQ 300 50 
5 SELIN 23332 LL Raw area SSG B 54 F 150 50 1 NO NO 2 T8 14 4 95 195 175 ADQ 310 50 
6 KANNAN 11458 
Frac BB Rt Flap 
cover B 32 M 165 60 1 NO NO 3 T5 14 5 100 245 230 ADQ 320 55 
7 VELU 35129 EX fixation B 56 M 160 55 2 NO NO 3 T6 15 4 105 220 205 ADQ 340 55 
8 LAXMANAN 36546 IM nailing B 27 M 170 65 1 NO NO 3 T6 16 5 95 230 215 ADQ 260 60 
9 DURAISAMY 16060 ILIZAROW fixation B 53 M 160 65 1 NO NO 3 T6 13 4 90 240 225 ADQ 300 60 
10 SELVAKUMAR 25022 LL SSG B 28 M 155 55 1 YES YES 4 T6 14 5 90 210 200 ADQ 310 60 
11 NAYAKAL 23372 Hemaroidectomy B 46 F 150 50 1 NO NO 3 T7 13 5 105 210 195 ADQ 320 55 
12 GOVINDARAJ 18542 Fistulectomy B 40 M 160 55 1 NO NO 3 T7 14 4 105 230 215 ADQ 340 55 
13 
MUTHURAMALIN
GAM 24306 lat sphinterectomy B 35 M 168 60 1 NO NO 3 T8 15 4 100 220 215 ADQ 300 45 
14 MALAIRAJAN 20723 
 Anal sph dilatation 
sphinterectomy B 24 M 155 45 1 NO NO 3 T7 14 5 100 225 215 ADQ 320 55 
15 MOMAMETHA 26416 lat sphinterectomy B 20 M 160 62 1 YES YES 4 T5  14 5 85 240 230 ADQ 330 50 
16 KANNAGI 27287 Hemaroidectomy B 30 F 155 60 1 NO NO 4 T6 15 5 90 210 195 ADQ 340 50 
17 SHANKAR 32429 
MED Gastronemius 
flap B 36 M 170 75 1 NO NO 5 T5 15 5 90 210 195 ADQ 320 55 
18 CHELLADURAI 35393 EX fixation B 35 M 165 60 1 YES YES 2 T6 12 4 95 210 190 ADQ 310 75 
19 CHINNAPANDI 27203 SSG B 52 M 168 66 1 NO NO 3 T6 12 4 95 215 210 ADQ 320 60 
20 RAMU 38203 
EXCISION of fem 
head B 52 M 152 66 1 NO NO 4 T7 13 5 100 215 195 ADQ 280 50 
21 RANI 38203 ORIF with mal scrw B 28 M 160 55 1 YES YES 3 T5 14 4 95 230 210 ADQ 290 55 
22 MUTHUKUMAR 29270 EX fixation B 31 M 165 70 1 YES YES 3 T4 13 4 105 230 220 ADQ 320 45 
23 CHINNTHAMBI 38040 EX fixation B 50 M 155 55 1 NO NO 4 T6 14 5 100 230 215 ADQ 320 60 
24 MALAICHAMY 41962 Implant removal B 27 M 160 56 1 YES YES 5 T7 15 7 90 190 175 ADQ 330 60 
25 DURAISAMY 44737 
Tension banding 
patella B 20 M 158 60 1 NO NO 4 T7 14 6 120 235 215 ADQ 340 60 
26 KRICHNAN 40518 Hemaroidectomy B 60 M 160 55 2 NO NO 3 T6 14 4 100 230 215 ADQ 320 55 
27 KULENDRAN 41369 Hemaroidectomy B 45 M 155 56 1 YES YES 3 T7 15 5 100 225 200 ADQ 320 60 
28 manikandan 45345 Hemaroidectomy B 42 M 163 68 1 NO NO 3 T4 15 4 95 200 185 ADQ 340 60 
29 prabu 78255 Hemaroidectomy B 40 M 155 59 1 YES YES 3 T6 14 5 95 230 210 ADQ 290 50 
30 SRINIVASAN 78050 Hemaroidectomy B 34 M 150 56 1 NO NO 3 T6 15 4 155 240 220 ADQ 320 60 
31 SARAVANAN 78358 Hemaroidectomy B 46 M 165 58 1 YES YES 4 T7 16 5 85 235 210 ADQ 320 55 
32 Jothi 79205 Hemaroidectomy B 50 F 150 52 1 NO NO 5 T6 15 7 80 230 215 ADQ 330 60 
33 PAULRAJ 78673 Hemaroidectomy B 48 M 166 58 1 YES YES 3 T6 14 4 100 200 185 ADQ 340 55 
34 SUBRAMANIAN 43101 Implant removal B 49 M 162 60 1 NO NO 3 T8 16 4 90 180 165 ADQ 330 75 
35 ALAGARRAJAN 34675 
Tumor resection 
with knee 
arthrodesis B 52 M 170 64 2 YES YES 4 T4 14 6 110 190 180 ADQ 320 75 
36 JEYAKUMAR 34682 TENDON REPAIR B 54 M 165 66 1 NO NO 3 T6 15 5 95 200 180 ADQ 310 55 
37 KURUMBAN 42721 Petellectomy B 55 M 167 60 1 NO NO 3 T6 16 4 95 230 200 ADQ 310 60 
38 ALAGARSAMI 42834 
Revision 
amputation B 55 M 164 59 2 YES YES 3 T6 13 4 100 220 205 ADQ 300 60 
39 ANANDAKUMAR 46586 
REPAR OF 
Tendon of Achilies B 38 M 150 55 1 NO NO 4 T7 14 6 100 230 215 ADQ 340 60 
40 IQBAL 49329 
Biopsy and 
curretage B 50 M 168 60 1 YES YES 3 T6 14 4 105 240 225 ADQ 320 60 
41 JEJAPRAKASH 28426 LL SSG B 55 M 160 64 1 NO NO 3 T5  13 4 75 240 215 ADQ 320 60 
42 SARASWATHI 28330 lat sphinterectomy B 34 F 150 52 1 NO NO 3 T5 14 4 100 230 210 ADQ 330 60 
43 PANDI 32845 Hemaroidectomy B 35 M 165 65 1 YES YES 3 T5 14 4 105 240 235 ADQ 340 55 
44 PASUPATHI 39996 lat sphinterectomy B 28 M 160 58 1 NO NO 3 T4 15 4 100 220 205 ADQ 330 55 
45 PITCHAIMANI 32484 lat sphinterectomy B 35 M 168 65 1 NO NO 2 T7 15 3 90 220 200 ADQ 330 45 
46 POONGODI 82885 Hemaroidectomy B 40 F 152 52 1 NO NO 4 T7 15 5 90 190 170 ADQ 320 50 
47 DHANALAKSHMI 38873 Hemaroidectomy B 42 M 155 55 1 NO NO 5 T6 15 6 95 230 210 ADQ 300 55 
48 pandiamal 38878 Hemaroidectomy B 50 F 154 58 1 NO NO 3 T6 14 5 85 210 195 ADQ 310 55 
49 VELUMANI 40828 Hemaroidectomy B 35 F 166 70 1 NO NO 3 T5  14 5 100 230 215 ADQ 340 55 
50 SHANTHI 40863 Hemaroidectomy B 45 F 152 55 1 NO NO 2 T6 15 3 110 240 215 ADQ 330 55 
51 BALAMURUGAN 50283 Tibia SCEW FIX R 29 M 165 60 1 NO NO 6 T10 16 10 65 160 140 ADQ 250 50 
52 SUBBIAH 27247 SSG R 50 M 168 56 2 NO NO 6 T12 15 12 60 165 145 ADQ 240 60 
53 HARIHARAN 42614 SSG R 47 M 165 65 1 NO NO 7 T10 15 10 55 175 150 ADQ 250 75 
54 VIJAYAN 52874 Implant removal R 32 M 155 60 1 YES YES 7 T8 15 9 55 180 135 ADQ 260 75 
55 CHELLPANDI 46249 
 EX FIX 
REALAINMENT R 20 M 168 69 1 NO NO 6 T10 16 10 60 165 165 ADQ 260 60 
56 CHANDRAN 46691 Hemaroidectomy R 43 M 160 65 1 NO NO 7 T8 16 8 65 160 135 ADQ 260 45 
57 RAJA 46727 Hemaroidectomy R 20 M 160 68 1 NO NO 8 T9 14 9 65 175 145 ADQ 240 45 
58 SEVANNAMAL 48629 Hemaroidectomy R 47 F 156 63 1 NO NO 6 T10 15 10 70 180 140 ADQ 210 60 
59 RAJENDRAN 45048 Hemaroidectomy R 56 M 170 69 1 NO NO 7 T10 15 12 55 155 130 ADQ 230 50 
60 SARAVANAMANI 50624 Hemaroidectomy R 20 M 158 54 1 NO NO 8 T12 14 10 50 145 120 ADQ 240 55 
61 ESWARI 50627 Hemaroidectomy R 23 F 160 52 1 NO NO 6 T8  15 9 70 165 145 ADQ 250 75 
62 
DHAKSHINAMUR
HY 51878 Hemaroidectomy R 47 M 167 62 1 NO NO 8 T9 16 8 60 175 155 ADQ 240 55 
63 BALU 48740 Hemaroidectomy R 47 M 168 70 1 YES YES 7 T10 16 8 65 165 145 ADQ 200 55 
64 SARASWATHI 56751 lat sphinterectomy R 31 F 158 56 1 NO NO 7 T10  14 9 65 175 140 ADQ 240 55 
65 murugesh 58593 Hemaroidectomy R 34 M 160 62 1 NO NO 8 T12 13 9 55 180 150 ADQ 240 55 
66 IBUTHAKAR 43941 SSG R 29 M 168 65 1 NO NO 7 T12 13 9 50 170 140 ADQ 250 50 
67 MUTHALAGAN 51854 Implant removal R 55 M 165 70 1 YES YES 6 T8 14 9 70 155 135 ADQ 260 55 
68 
MUTHUMARIAM
AL 48804 SSG R 41 F 152 56 1 NO NO 6 T10 15 10 65 185 160 ADQ 260 55 
69 KANAGAVEL 55088 ILIZAROW fixation R 33 M 168 68 1 NO NO 6 T10 14 10 60 160 150 ADQ 240 60 
70 RAMAN 57396 
WOUND DEBRIMA  
WITH AB beading R 20 M 165 64 1 NO NO 7 T9 15 10 45 145 130 ADQ 260 75 
71 RAMAKRISHNAN 53850 ak amputation R 40 M 158 55 1 NO NO 5 T10 17 9 60 150 130 ADQ 240 60 
72 MURTHY 49931 
Revision 
amputation R 44 M 150 62 1 NO NO 6 T10 15 9 65 180 165 ADQ 230 50 
73 ANGAMMAL 45688 FILAP COVER R 48 F 158 55 1 NO NO 6 T10 14 11 65 155 140 ADQ 220 55 
74 PUSHPAM 57870 EX fixation R 50 M 165 50 1 NO NO 6 T12 15 10 55 150 145 ADQ 240 75 
75 krishnan 63784 Implant removal R 48 M 162 58 1 NO NO 6 T10 15 10 55 165 145 ADQ 230 50 
76 ARUMUGAM 55037 EX fixation R 56 F 154 58 1 NO NO 7 T10 13 10 45 155 145 ADQ 220 55 
77 SIVAKUMAR 60165 
Frac talus BLAIR 
FUSION R 32 M 164 60 1 NO NO 5 T10 12 8 60 180 160 ADQ 230 75 
78 SIVA 64982 
Revision 
amputation R 20 M 168 62 1 NO NO 7 T12 15 10 45 120 100 ADQ 250 55 
79 MUTHU 55516 SSG R 38 M 158 60 1 NO NO 6 T9 14 11 70 130 120 ADQ 260 60 
80 SETHURAMAN 58892 Hemaroidectomy R 30 M 162 65 1 NO NO 8 T9 13 10 55 150 135 ADQ 270 45 
81 MOOKIYA 58892 Hemaroidectomy R 40 M 158 60 1 NO NO 7 T10 14 10 45 160 145 ADQ 230 45 
82 KANNAN 60219 lat sphinterectomy R 40 M 160 62 1 NO NO 6 T10 14 8 60 175 150 ADQ 220 45 
83 MUTHARAMMAL 62809 lat sphinterectomy R 22 M 158 55 2 NO NO 6 T12 15 8 60 160 140 ADQ 230 55 
84 ALAGU 62774 Hemaroidectomy R 55 F 155 52 1 NO NO 6 T10 15 8 60 160 135 ADQ 240 55 
85 MOOKAN 66043 Hemaroidectomy R 50 M 162 60 1 NO NO 7 T12 16 9 65 165 150 ADQ 250 55 
86 SELVI MARY 65925 lat sphinterectomy R 58 M 168 65 1 NO NO 5 T9 13 9 70 175 165 ADQ 260 60 
87 JEYAKUMAR 65998 Hemaroidectomy R 30 F 154 51 1 NO NO 6 T8 13 10 165 165 150 ADQ 230 55 
88 BABU 67685 lat sphinterectomy R 23 M 162 62 1 NO NO 5 T10 15 9 150 160 140 ADQ 240 50 
89 OCHAKAL 67799 Hemaroidectomy R 34 M 163 58 1 NO NO 4 T10 13 10 75 155 135 ADQ 240 50 
90 
SHANMUGAABIR
AMI 67742 Hemaroidectomy R 58 F 155 54 2 NO NO 6 T12 16 8 75 170 150 ADQ 240 45 
91 CHANDRAN 71129 Hemaroidectomy R 53 F 156 54 1 NO NO 6 T10 16 9 50 140 130 ADQ 230 45 
92 KALLIMUTHU 72811 Hemaroidectomy R 52 M 170 64 1 NO NO 8 T8 15 10 60 120 100 ADQ 240 45 
93 BASKARAN 72944 Hemaroidectomy R 42 M 163 58 1 NO NO 7 T8 14 10 65 190 175 ADQ 250 45 
94 MD YUSUF 75054 Hemaroidectomy R 28 M 168 65 1 NO NO 6 T10 14 8 65 165 150 ADQ 250 45 
95 VALLIAN 74081 Hemaroidectomy R 48 m 155 52 1 NO NO 7 T10 16 9 55 185 160 ADQ 250 55 
96 ARUMUGAM 65130 Hemaroidectomy R 55 M 165 65 1 NO NO 7 T12 15 9 55 185 155 ADQ 220 75 
97 BALAKRISHNAN 67939 Implant removal R 39 M 168 65 1 NO NO 6 T10 15 8 50 165 155 ADQ 220 60 
98 MURUGESAN 60118 SSG R 60 M 160 62 1 NO NO 6 T10 15 12 60 165 145 ADQ 240 60 
99 MURUGAN 49497 FLAP COVER R 21 M 166 65 1 NO NO 4 T10 20 8 75 145 125 ADQ 240 75 
100 VISUVASAM 41147 Hemaroidectomy R 50 M 165 56 2 NO NO 7 T12 15 9 45 170 150 ADQ 250 50 
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1 B 86 86 84 84 84 80 78 78 78 75 74 74 72 74 74 74 70 126 124 126 126 124 120 120 120 124 116 116 116 114 114 116 110 120
2 B 100 100 98 88 93 95 84 84 84 86 80 86 90 89 86 90 138 134 134 136 136 130 130 130 138 134 138 134 130 128 124 120
3 B 76 76 75 76 74 72 72 74 72 70 70 72 72 70 72 112 114 110 110 98 98 98 100 102 106 99 98 112 114 112
4 B 86 87 86 85 76 75 75 80 87 76 72 87 88 90 120 120 120 118 116 116 118 110 110 100 102 116 118 118
5 B 76 74 73 76 72 65 64 63 64 76 80 87 78 87 130 130 128 130 132 120 112 120 118 118 120 130 120 124
6 B 85 78 78 77 74 72 78 60 64 62 62 67 76 78 90 120 120 124 118 116 112 110 118 120 118 114 116 112 112 120
7 B 80 80 76 78 78 80 80 76 74 72 76 77 87 90 93 124 126 120 120 120 124 120 118 112 110 106 108 104 116 120
8 B 74 75 78 79 80 76 75 74 73 67 66 63 78 89 87 89 140 140 138 134 120 120 126 130 120 130 130 130 126 120 112 118
9 B 76 78 79 67 67 64 65 67 67 76 76 87 78 78 89 91 130 130 132 122 120 118 116 118 116 112 110 106 108 102 112 118
10 B 90 89 85 86 76 68 66 68 62 60 62 62 62 65 76 78 134 130 130 124 120 112 110 94 96 86 108 110 106 100 110 124
11 B 100 98 99 96 77 87 85 88 94 98 93 98 99 103 109 110 110 110 108 110 106 98 98 100 102 104 102 109 112 110
12 B 78 79 76 76 75 65 64 62 74 78 80 80 82 81 88 130 130 120 124 124 120 118 116 112 118 120 120 124 120 128
13 B 98 98 97 90 89 82 83 83 84 85 86 90 87 88 130 126 126 130 120 118 118 110 120 122 126 128 130
14 B 75 76 76 75 74 73 72 72 69 67 66 64 63 63 62 120 120 120 120 124 118 118 118 112 110 108 108 106 110 116
15 B 92 90 92 90 89 88 88 68 70 56 94 97 95 98 124 124 124 122 120 116 100 98 98 86 100 110 116 116
16 B 90 87 89 87 82 83 83 84 89 86 88 88 87 89 118 116 118 120 110 110 112 112 114 116 110 118 120 122
17 B 78 76 75 76 73 72 71 71 69 66 63 62 77 78 88 140 140 134 134 130 134 130 120 124 124 128 128 122 120 124
18 B 74 74 74 76 78 82 60 56 80 78 88 78 89 98 88 86 82 134 134 132 132 134 114 110 86 100 110 112 120 120 124 138 140 132
19 B 87 87 86 86 80 80 76 65 66 62 76 78 79 79 82 83 110 110 112 108 108 106 102 100 98 98 98 100 102 112 120 120
20 B 87 64 87 98 93 87 77 72 73 75 75 76 78 78 120 120 124 122 122 12 118 116 112 110 112 102 100 112 124
21 B 87 87 88 88 88 82 80 70 55 76 80 80 83 82 89 120 120 124 112 110 106 110 102 100 86 110 112 116 106 106
22 B 86 88 76 86 88 76 80 76 78 88 88 87 95 98 126 126 112 106 98 98 82 110 108 116 120 116 132
23 B 80 78 77 79 80 89 77 78 67 67 68 77 78 73 78 69 118 118 116 116 118 116 110 108 104 102 106 108 110 120 120 124
24 B 102 100 98 98 98 88 78 78 54 76 76 76 78 89 89 90 112 12 116 108 104 104 108 100 86 110 112 112 108 108 108 110
25 B 87 87 89 89 88 87 86 85 84 83 87 78 78 78 67 123 130 124 124 120 112 114 126 112 110 108 106 104 118 116
26 B 76 76 78 75 74 73 72 72 74 66 65 65 63 62 74 78 120 120 120 120 116 116 112 110 110 108 116 118 120 122 120 126
27 B 89 88 88 80 80 78 65 66 56 80 76 76 76 86 88 86 130 130 126 128 108 100 92 92 86 112 118 114 116 112 120 120
28 B 72 72 70 71 78 62 66 65 66 67 63 70 72 76 112 112 110 110 110 108 108 106 106 108 110 112 112 114
29 B 100 100 102 102 89 98 87 88 70 54 77 70 80 88 128 128 124 122 110 110 112 98 88 106 110 112 120 120
30 B 87 78 78 76 75 74 73 72 72 70 70 76 66 67 78 88 120 120 120 118 118 116 116 114 114 114 112 112 120 122 124 124
31 B 92 92 90 90 85 82 80 78 68 65 58 78 80 77 78 136 134 130 130 124 124 122 112 100 98 88 112 188 128 130
PULSE RATE SYSTOLIC BLOOD PRESSURE
32 B 75 75 74 73 73 72 67 68 65 64 63 67 78 78 79 80 120 120 116 118 118 118 118 116 112 112 110 110 110 100 98 124
33 B 76 78 75 72 72 70 74 62 55 77 89 89 90 87 87 124 124 126 112 108 108 106 94 86 106 118 120 118 118 118
34 B 70 73 72 73 76 76 76 78 78 78 89 89 90 90 92 95 120 120 112 114 120 120 120 120 112 120 120 118 120 120 124 120
35 B 100 100 90 89 88 62 77 63 59 94 98 99 99 100 102 108 102 132 132 130 110 108 102 100 100 98 94 88 100 112 120 122 124 120
36 B 72 72 73 70 65 66 66 65 63 67 68 70 72 74 76 130 130 124 124 122 110 112 120 112 112 110 118 110 100 114
37 B 86 86 84 83 83 81 87 76 76 66 65 64 63 68 70 78 118 118 116 116 114 110 108 112 120 120 118 112 118 120 120 124
38 B 88 88 89 84 83 81 80 76 64 54 78 80 77 76 77 78 110 112 116 108 106 108 99 99 88 110 110 112 98 98 110 108
39 B 70 70 70 67 65 65 60 62 67 68 69 70 72 73 73 78 120 120 120 118 118 116 116 114 112 100 102 100 98 100 112 120
40 B 102 98 98 100 102 88 78 67 55 87 98 98 108 110 110 112 128 128 118 110 108 102 98 98 86 114 112 126 128 128 130 130
41 B 80 80 78 78 79 76 74 71 70 76 87 74 72 72 73 120 112 114 114 120 120 120 112 110 112 112 110 108 110 112 120
42 B 76 76 74 72 70 70 72 67 68 65 65 65 67 70 71 72 134 130 130 124 124 124 130 120 120 112 128 122 120 120 118 118
43 B 78 78 75 78 78 67 86 78 80 87 89 76 68 66 67 78 134 126 124 128 128 122 104 108 108 112 108 120 124 128 112
44 B 78 76 78 77 67 60 65 62 61 62 68 78 78 79 80 110 110 110 108 110 112 108 102 102 100 98 100 110 112 116
45 B 74 74 76 76 78 78 79 72 70 65 63 60 71 70 114 112 114 110 110 110 108 112 106 108 112 110 110
46 B 80 80 82 82 80 82 80 78 76 75 75 70 66 65 66 122 124 124 120 118 114 110 110 112 110 110 112 116 120
47 B 76 76 75 75 74 76 78 77 80 76 76 76 74 73 66 64 130 130 124 126 116 110 102 108 108 110 110 112 120 124 130
48 B 80 78 78 76 66 65 64 66 77 76 76 75 70 65 67 128 128 124 124 120 112 116 118 114 114 116 118 112 120 120
49 B 76 78 78 78 80 80 82 67 67 66 65 77 78 78 79 122 122 122 124 120 112 118 120 120 124 126 132 130 132 130
50 B 78 78 78 80 67 66 78 78 67 89 99 90 78 76 74 124 124 126 118 114 114 112 112 104 112 110 108 112 114 120
51 R 90 90 90 90 88 88 84 84 82 82 80 78 78 78 76 80 86 134 134 132 124 122 122 120 112 110 106 102 100 104 110
52 R 87 87 86 86 78 77 76 76 75 76 76 76 70 78 66 70 120 120 120 118 116 116 112 112 110 108 106 104 110 112 114 120
53 R 80 80 78 78 76 76 80 82 82 80 80 76 75 75 67 67 66 110 112 112 114 116 112 110 110 110 110 108 104 112 112 118 120 122
54 R 76 76 78 66 72 72 64 64 58 80 86 76 76 88 90 92 92 134 130 120 106 120 120 100 98 88 116 116 112 120 130 124 124 130
55 R 78 78 76 76 75 70 66 64 67 77 78 67 89 89 77 78 120 120 120 120 120 120 112 112 110 106 108 110 110 110 118 120
56 R 87 88 86 84 84 80 78 78 76 75 70 68 70 124 124 120 112 112 116 118 118 112 112 110 120 120
57 R 88 88 86 87 87 86 80 78 76 76 70 67 77 124 124 120 118 118 112 114 110 110 114 114 110 110
58 R 98 89 78 78 76 76 78 78 74 76 79 66 68 70 120 120 120 116 118 116 116 110 110 112 112 110 106 108 110 110
59 R 90 86 87 87 86 85 85 70 78 78 76 87 90 92 95 110 110 110 108 104 100 106 108 110 110 110 110 112 112
60 R 92 90 89 89 88 87 87 76 76 78 79 80 82 80 82 84 110 112 112 110 108 105 104 104 100 112 112 114 116 118 110
61 R 77 78 77 76 74 74 72 70 70 67 68 68 70 76 78 80 76 120 124 120 118 118 112 112 114 116 112 110 110 100 106 104 112 120
62 R 78 76 76 76 70 70 67 68 67 60 63 63 65 65 76 130 124 124 130 122 124 120 118 114 112 110 112 120 128 130
63 R 77 78 78 72 70 68 64 67 54 78 80 78 92 90 89 124 124 124 120 120 108 100 96 88 110 118 112 128 124 124
64 R 77 76 75 74 76 66 67 60 62 60 67 68 78 73 79 124 124 124 120 120 110 110 106 108 110 10 118 120 120 120
65 R 78 76 75 74 74 75 76 78 66 65 62 74 74 75 80 124 120 120 120 120 110 110 108 108 106 104 110 118 114 120
66 R 78 78 76 73 74 67 62 60 67 67 78 72 74 76 120 120 120 118 116 116 112 114 116 112 110 110 108 110
67 R 98 100 102 98 76 67 67 62 60 52 80 82 82 84 94 134 130 124 120 112 102 108 100 86 100 100 118 112 120 120
68 R 82 86 80 80 82 78 76 72 70 65 66 70 76 80 90 120 120 120 120 124 118 118 116 116 116 118 118 116 110 112
69 R 80 87 86 82 80 78 67 68 62 79 80 90 92 99 100 100 120 120 120 120 118 112 112 110 108 110 110 110 110 112 120 120
70 R 78 76 73 87 85 65 78 80 88 90 100 106 110 90 98 96 100 120 120 120 120 112 112 112 116 118 112 112 114 114 112 118 120 120
71 R 89 89 84 87 87 86 89 89 76 75 74 66 62 67 78 90 124 120 120 126 124 124 112 118 118 110 120 126 130 130 124 120
72 R 70 70 70 89 82 78 74 74 76 76 80 87 86 78 120 120 118 118 114 114 112 112 114 116 118 118 120 120
73 R 75 74 74 76 74 72 72 65 76 73 72 80 89 89 80 140 120 118 116 114 114 112 112 112 112 108 108 110 112 112
74 R 78 78 76 76 74 74 76 70 67 68 68 80 78 82 82 90 98 118 120 118 ### 116 114 114 112 112 112 112 118 116 116 118 122 122
75 R 79 78 76 66 66 64 64 60 76 77 78 80 89 84 120 120 120 118 116 116 114 114 112 112 112 112 112 112
76 R 89 72 76 76 75 75 87 98 98 98 110 100 108 106 110 110 110 108 108 104 100 100 100 98 98 98 98 98 110 110
77 R 87 77 78 76 78 76 75 73 72 71 67 67 78 78 89 89 90 126 124 120 120 120 118 116 112 112 116 118 118 110 120 124 130 130
78 R 76 75 76 80 82 82 84 87 88 89 90 90 94 100 98 120 136 136 130 130 130 132 124 122 120 118 112 110 118 120
79 R 78 76 74 78 83 88 89 90 97 98 100 110 109 110 112 98 128 124 124 120 118 116 110 120 112 118 116 118 120 120 122
80 R 84 82 80 86 83 82 90 94 94 98 96 99 93 130 130 130 130 124 120 120 120 118 118 116 112 110
81 R 80 80 78 80 80 80 83 84 85 90 90 96 94 120 120 120 118 116 116 110 120 120 120 120 114 112
82 R 80 80 80 78 79 65 76 89 78 78 89 98 99 110 108 110 106 112 110 102 100 98 98 100 112 116
83 R 80 78 77 79 87 86 84 85 82 88 90 87 87 85 90 112 112 112 112 110 110 110 106 106 102 100 108 102 110 110
84 R 74 74 72 88 98 100 89 90 93 94 94 88 89 85 89 116 116 116 112 112 112 110 110 110 104 106 102 100 110 110
85 R 75 75 73 87 88 80 82 80 82 84 86 88 89 90 98 128 126 126 126 124 124 122 122 120 120 114 110 110 112 112
86 R 76 76 76 78 80 88 88 89 80 93 95 98 98 100 102 105 112 130 130 126 126 128 120 112 110 110 110 108 110 112 112 112
87 R 78 78 77 80 77 78 87 80 80 80 85 88 88 89 90 120 124 120 118 112 110 108 110 110 116 116 116 116 112 120
88 R 78 78 78 78 80 80 83 82 80 82 82 80 88 90 118 118 118 114 112 110 112 110 108 106 100 110 114 120
89 R 67 66 67 77 78 78 79 80 87 90 94 92 90 90 120 120 120 120 116 114 110 110 108 106 104 110 112 112
90 R 78 77 77 89 78 65 65 76 76 87 80 93 95 98 120 120 120 116 116 12 112 112 110 110 112 112 102
91 R 72 67 78 80 88 89 76 66 89 90 90 92 99 120 120 118 118 120 120 120 116 112 112 110 112 110
92 R 78 77 84 80 78 78 72 70 75 76 78 78 78 130 124 124 122 120 120 118 118 112 110 110 128 120
93 R 91 86 87 78 87 87 80 82 99 100 109 98 88 120 120 120 122 122 116 112 112 108 104 106 100 100
94 R 99 98 87 80 82 83 84 85 78 88 98 90 98 110 108 108 110 108 100 100 98 100 98 104 106 110
95 R 89 87 86 84 87 80 80 78 78 76 72 70 87 88 90 124 124 124 120 120 120 124 120 120 116 116 120 120 112 112
96 R 78 79 78 89 78 89 88 78 74 76 77 87 98 89 100 98 90 128 128 126 126 126 122 120 120 116 116 112 116 118 120 120 112 120
97 R 88 80 76 78 89 89 90 94 89 90 99 100 89 96 87 90 124 124 120 120 120 116 116 112 114 110 108 100 112 112 118
98 R 89 88 76 78 78 80 82 85 86 88 87 86 80 88 90 78 122 120 120 122 120 114 112 110 114 114 112 100 102 104 106 110
99 R 72 70 74 78 78 78 74 75 76 77 78 78 62 65 67 78 88 122 120 120 122 120 116 116 112 112 110 110 110 112 112 118 120 122
## R 76 78 78 78 88 90 90 98 86 93 90 89 89 134 132 132 130 132 132 ### 126 120 120 120 118 120 120
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82 84 84 82 82 80 80 80 78 78 78 74 74 72 74 74 76 100 100 100 100 100 99 100 100 100 100 100 98 99 100 100 100 100
80 84 84 80 82 80 82 80 76 72 74 80 76 74 74 100 100 100 100 100 100 100 100 100 100 99 100 99 99 100
78 76 67 72 68 72 66 76 74 72 72 70 70 70 74 99 99 98 98 99 99 98 98 98 99 97 98 99 99 99
80 80 76 78 70 72 74 76 74 68 68 72 72 74 100 100 100 100 100 100 100 100 99 100 100 100 100 99
76 80 80 80 78 78 70 68 80 82 78 78 78 82 99 99 98 98 99 98 99 98 98 98 99 99 98 98
76 76 74 74 76 72 70 68 68 72 74 74 76 76 78 98 99 98 99 99 98 99 99 99 98 98 98 98 99 99
82 80 80 78 78 76 74 72 70 76 76 76 78 80 78 100 100 100 100 100 100 99 99 100 100 99 98 99 100 98
84 84 84 82 82 80 80 82 80 80 82 78 76 76 78 76 98 99 99 98 99 99 100 100 99 99 98 100 99 100 100 100
82 82 80 78 78 76 76 74 76 78 80 78 82 82 76 76 100 100 100 98 99 99 99 99 99 99 98 99 98 99 99 99
80 80 80 78 78 76 78 64 68 56 68 68 72 72 74 74 99 99 99 98 99 99 99 99 99 99 99 99 98 98 99 99
82 80 78 72 68 66 76 76 70 68 68 68 68 70 70 100 100 100 99 99 100 99 99 99 100 100 98 99 100 99
64 64 70 70 72 72 70 72 72 74 72 70 76 80 68 99 99 99 98 99 99 99 98 99 99 100 100 100 100 99
70 68 68 68 68 70 64 68 68 72 72 70 72 100 100 100 100 100 99 99 100 100 100 99 99 99
86 86 86 82 80 78 78 78 76 76 72 72 70 76 78 99 100 100 100 99 99 98 99 99 98 98 99 99 99 100
82 82 82 84 82 84 84 70 64 60 72 82 84 82 100 100 98 99 99 99 99 99 98 99 99 100 100 99
76 72 72 70 70 72 70 72 80 82 80 80 78 68 99 100 100 99 99 99 98 98 99 98 99 98 99 99
86 86 68 80 80 80 78 78 78 82 80 80 80 78 80 99 99 100 99 99 100 99 99 99 100 100 99 99 100 100
72 72 74 72 70 68 66 54 78 80 78 76 76 78 74 72 76 99 99 99 99 98 99 98 98 99 99 99 98 99 98 98 99 99
80 80 82 82 82 80 78 78 78 72 74 74 76 76 78 78 99 100 100 100 99 99 99 99 100 100 99 99 100 100 100 99
80 80 82 80 78 78 74 74 68 68 66 64 64 68 99 99 98 98 99 100 100 99 99 98 100 100 99 99
80 80 80 76 76 74 72 64 62 56 76 78 80 80 78 98 99 98 99 99 98 98 98 98 98 99 99 99 99 99
82 82 78 70 72 72 60 76 78 70 68 70 70 100 100 100 99 99 100 100 100 99 99 99 100 100
86 82 80 78 78 78 76 74 72 72 78 80 82 82 80 78 99 99 99 98 98 99 99 99 98 99 99 99 100 99 98 99
72 72 72 70 68 66 68 70 56 76 68 68 68 66 70 70 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
76 76 72 72 70 70 78 74 72 70 68 66 64 68 68 100 99 99 99 99 99 99 99 98 98 98 98 99 99 99 100
86 86 82 82 80 80 82 80 78 78 76 74 72 70 70 99 99 100 100 100 100 99 100 99 100 100 100 100 100 100
82 82 82 86 84 80 80 76 74 54 74 82 82 82 86 86 99 99 99 99 99 98 98 99 98 99 98 98 99 98 98 99
86 80 86 84 84 82 82 78 78 78 78 74 68 68 70 100 100 100 99 99 98 99 99 99 99 99 99 100 99 99 99
80 80 78 78 66 68 54 77 78 88 78 80 80 82 100 100 100 100 99 99 100 100 99 99 100 100 99 100
76 76 74 74 72 72 74 76 76 68 68 68 74 72 70 72 100 100 100 99 99 99 99 99 98 99 100 100 100 100 100 100
80 80 80 80 76 76 76 66 54 72 72 76 78 80 80 99 100 100 99 99 99 99 98 98 98 98 99 99 99 99
DIASTOLIC BLOOD PRESSURE SPO2
76 76 76 76 76 74 74 72 72 70 70 70 68 68 70 70 100 100 99 99 99 98 98 99 99 99 98 99 100 100 100 100
80 82 80 78 76 76 78 67 56 78 78 80 82 80 82 100 100 100 100 100 100 99 100 100 100 100 100 100 99 100
82 82 80 80 78 78 76 74 70 74 78 80 80 80 82 82 80 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
84 83 82 80 82 80 78 76 76 68 58 78 80 80 82 82 84 99 99 99 99 100 100 99 100 100 100 100 100 100 100 100 99 99
76 76 76 76 74 74 72 72 70 70 72 76 72 78 80 99 99 99 99 98 98 99 99 99 98 98 98 98 99 99
80 84 84 82 80 78 80 78 68 68 66 72 72 76 78 78 100 99 100 100 99 99 100 100 100 100 100 100 100 100 99 99
70 70 68 70 64 62 68 66 58 67 70 70 72 74 74 74 100 99 99 99 99 99 99 100 100 99 100 100 100 100 100 99
76 78 78 78 80 78 68 68 66 68 72 74 76 78 76 74 100 100 99 99 100 99 99 100 100 99 99 99 99 99 99 100
82 82 80 72 68 64 64 56 76 78 80 80 80 78 78 74 100 100 100 100 99 100 99 98 98 99 99 99 99 100 100 100
80 82 82 82 82 78 78 78 78 80 82 80 78 76 76 78 100 100 99 99 99 100 100 99 100 100 100 100 100 99 99 99
80 80 80 78 78 76 74 74 74 72 74 72 74 72 78 76 99 98 99 99 99 99 99 99 99 99 98 98 98 98 99 99
82 80 80 74 74 72 72 68 56 78 80 88 80 78 82 76 99 99 100 100 99 100 100 99 99 100 100 100 100 100 99
80 80 82 78 78 76 76 74 72 72 72 72 70 70 68 68 100 100 100 100 100 100 100 100 100 99 99 99 99 99 100
76 76 76 76 76 74 72 70 72 68 68 68 66 76 78 78 100 100 100 99 99 99 99 99 99 100 100 100 100
80 82 86 82 80 80 70 78 76 76 76 78 82 82 99 99 99 99 99 99 99 97 98 99 99 99 99 99
80 79 76 74 76 76 66 66 72 72 78 78 72 80 72 99 99 99 98 99 99 99 99 99 98 98 99 99 99 99
82 82 82 80 80 76 70 68 68 68 70 72 74 72 72 100 100 100 99 99 99 99 98 99 99 100 100 100 100 100
76 76 76 76 74 74 72 72 80 82 82 80 78 76 72 100 100 99 100 100 99 99 99 99 98 99 99 98 99 99
78 76 76 76 74 72 72 71 76 76 66 78 68 78 76 99 99 100 100 100 99 99 98 99 99 99 99 99 100 100
80 80 80 80 82 84 78 78 74 68 66 68 72 74 100 100 100 100 99 99 100 100 100 99 99 99 99 100
72 72 72 74 68 66 66 62 70 70 68 74 74 72 76 78 100 99 99 98 99 98 99 99 98 99 99 99 98 100 100 98
80 82 82 82 80 80 78 80 82 88 76 86 80 82 80 82 82 100 100 100 100 100 99 99 99 100 100 100 100 100 100 100 100 100
82 80 82 78 80 72 68 78 76 74 72 68 70 72 74 76 78 100 100 100 100 99 99 100 99 99 100 99 99 100 99 99 100 100
84 76 76 66 68 70 72 74 74 78 80 76 76 78 76 76 99 99 99 99 99 99 99 99 98 98 98 99 99 98 99 99
72 76 76 78 80 78 68 66 64 68 70 72 72 100 100 100 99 100 100 100 100 100 100 100 100 100 99
82 82 80 78 78 78 74 74 72 72 72 74 70 100 100 99 99 99 99 98 100 99 99 98 99 99
78 78 82 82 80 78 78 76 76 74 74 72 72 78 88 82 100 100 100 100 100 99 99 100 100 10 100 99 99 99 99
80 80 78 78 76 76 76 78 78 78 80 68 68 66 100 100 100 100 99 99 99 99 99 99 99 99 99 99
68 68 68 66 64 66 68 68 70 68 70 70 72 70 72 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99
72 72 72 70 70 68 68 68 66 66 68 70 70 72 72 76 76 99 99 99 99 98 98 99 99 99 99 99 98 99 99 98 98 98
80 80 80 82 82 80 82 80 78 78 78 78 76 76 76 100 100 100 100 100 100 100 100 100 100 100 100 99 99 99
78 80 80 78 80 78 67 66 56 72 72 72 78 70 68 98 99 99 98 100 100 98 99 99 98 98 99 99 100 100
82 82 82 80 78 78 78 76 76 74 74 76 80 80 78 100 100 99 99 99 99 98 99 99 100 100 100 99 99 100
86 86 84 84 82 82 80 80 80 78 78 78 80 80 80 100 100 100 100 100 99 99 100 99 100 100 100 100 100 100
80 80 80 80 80 78 78 76 76 76 74 74 72 70 99 99 99 99 99 99 99 99 99 98 98 99 99 99
78 80 78 76 78 72 66 64 54 70 70 72 76 78 72 100 100 100 100 100 100 99 99 99 100 100 100 100 99 99
78 78 78 76 76 76 72 76 76 74 70 72 72 72 70 100 100 99 99 99 99 98 99 99 99 98 99 99 99 99
76 76 76 72 76 74 78 80 80 80 80 67 76 76 76 76 100 100 100 100 100 100 100 99 99 100 100 100 100 100 100 100
76 76 76 76 76 76 74 74 74 74 70 70 72 72 76 76 78 99 99 99 98 98 99 99 99 98 98 99 99 99 99 100 100 100
76 76 76 74 74 74 74 72 72 68 68 68 68 66 70 70 100 100 100 100 99 99 99 99 99 98 98 99 99 100 99 99
76 76 76 74 74 76 76 78 78 76 76 76 66 68 99 99 99 99 99 99 99 99 99 99 99 98 98 99
72 70 70 68 68 72 71 70 72 70 72 76 78 76 76 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99
72 76 76 76 76 76 80 82 82 84 82 76 76 72 72 72 78 100 99 99 99 99 99 99 99 99 99 99 99 99 100 99 100 100
80 80 80 80 78 76 76 76 76 76 72 70 70 76 100 100 99 99 99 99 99 99 99 100 99 99 99 100 99
78 78 78 76 76 76 78 78 78 78 78 78 80 78 76 99 98 97 98 87 97 98 98 98 98 99 99 98 99 99 99
78 78 78 80 80 80 78 78 74 74 72 70 70 70 72 72 76 100 100 99 99 100 100 100 100 100 100 100 100 100 99 99 99 100
76 76 74 74 78 78 76 70 68 68 66 66 64 70 70 100 100 100 100 100 100 99 99 99 100 100 99 100 100 100
86 86 86 86 86 82 82 82 80 80 80 76 78 76 72 74 99 99 99 99 98 97 97 98 99 99 99 99 99 99 100 100
84 82 82 80 80 80 80 80 80 78 78 78 76 100 100 100 100 100 100 100 100 100 99 99 99 99
84 84 84 84 84 84 82 82 80 80 78 78 78 99 99 99 99 99 100 100 100 100 100 100 99 99
86 86 86 86 84 84 82 80 80 78 78 78 68 100 100 100 100 99 99 99 99 99 99 100 100 100
82 82 82 80 80 80 78 78 78 76 74 74 72 70 70 99 98 99 98 98 98 99 99 99 99 100 99 100 100 100
80 80 78 78 78 78 76 76 76 72 72 70 70 72 74 99 99 99 99 99 100 100 100 100 99 99 99 100 100 99
82 82 82 80 80 80 80 78 78 76 72 72 70 68 68 98 98 98 97 97 97 98 98 98 98 98 99 100 100 99
80 80 80 80 78 78 78 78 78 76 76 76 72 72 72 70 99 99 99 99 99 99 99 99 99 99 99 99 99 100 99 100
80 80 80 80 80 80 78 78 68 68 70 70 72 72 74 100 100 100 100 100 100 100 100 100 100 100 100 100 99 99
78 78 78 78 76 76 76 76 74 74 74 72 70 70 99 99 98 99 99 98 99 99 99 99 99 99 99 99
78 78 76 76 76 74 74 72 72 70 70 72 64 74 99 97 97 98 99 98 98 98 98 99 99 100 100 99
76 74 74 76 74 74 68 68 72 72 74 74 80 100 100 100 100 100 100 99 99 99 99 99 99 99
78 78 76 72 72 70 70 72 76 74 74 72 70 100 100 99 99 99 99 100 100 100 100 100 99 99
80 80 80 82 82 78 87 76 76 76 72 72 72 100 100 100 100 100 99 99 100 99 99 99 98 98
82 86 86 82 80 80 80 82 76 76 74 74 72 99 99 98 99 99 100 100 100 100 100 100 100 100
80 80 80 78 78 78 78 76 76 76 722 72 78 99 99 98 98 98 99 99 99 98 96 97 99 98
82 82 82 80 80 80 80 82 80 80 82 80 82 80 80 99 99 99 99 100 100 100 100 100 100 100 100 100 100 99
78 78 78 78 76 76 70 70 72 72 72 74 70 72 72 76 80 100 100 100 10 99 99 99 99 98 99 99 99 99 99 99 99 100
80 80 80 80 80 80 80 80 80 72 72 70 74 74 80 80 99 99 99 99 99 98 98 99 99 100 100 100 100 100 99 99
82 80 80 78 78 80 82 76 76 72 72 78 72 72 78 80 100 100 100 99 98 99 98 99 99 99 98 97 98 99 99 100
82 82 82 82 82 80 80 80 80 78 78 78 78 78 76 76 80 99 99 99 99 99 99 99 99 100 100 100 98 99 99 99 99 99
82 80 80 76 76 76 76 76 74 72 72 70 70 70 100 100 100 100 100 100 100 100 100 99 99 99 99 100
